Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
QuintilesIMS
Dow
Fish and Richardson
Cipla
Deloitte
Chinese Patent Office
Farmers Insurance
UBS

Generated: June 24, 2018

DrugPatentWatch Database Preview

PEPCID Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Pepcid, and when can generic versions of Pepcid launch?

Pepcid is a drug marketed by Salix Pharms, Merck, Valeant Pharms North, J And J Consumer Inc, and Merck Sharp Dohme. and is included in nine NDAs. There are two patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in PEPCID is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and seventy-five drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.
Drug patent expirations by year for PEPCID
Pharmacology for PEPCID
Synonyms for PEPCID
(1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide
(1Z)-2-amino-4-{[2-(2,2-diamino-1-azavinyl)(1,3-thiazol-4-yl)]methylthio}-1-az abut-1-enesulfonamide
(1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide
(1Z)-N'-(aminosulfonyl)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)thio]propanimidamide
(Z)-3-((2-(DIAMINOMETHYLENEAMINO)THIAZOL-4-YL)METHYLTHIO)-N'-SULFAMOYLPROPANIMIDAMIDE
1-AMINO-3-[[[[2-[(DIAMINOMETHYLENE)AMINO]-4-THIAZOLYL]METHYL]THIO]PROPYLIDENE]SULFAMIDE
2-[4-[2-(amino-sulfamoylimino-methyl)ethylsulfanylmethyl]-1,3-thiazol-2-yl]guanidine
3-(((2-((Aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)propanimidamide
3-(((2-((Diaminomethylene)amino)-4-thiazolyl)methyl)thio)-N(sup 2)-sulfamoylpropionamidine
3-(((2-((Diaminomethylene)amino)thiazol-4-yl)methyl)thio)-N'-sulfamoylpropanimidamide
3-(((2-guanidinothiazol-4-yl)methyl)thio)-N-sulfamoylpropanimidamide
3-((2-(DIAMINOMETHYLENEAMINO)THIAZOL-4-YL)METHYLTHIO)-N-SULFAMOYLPROPANIMIDAMIDE
3-((2-(DIAMINOMETHYLENEAMINO)THIAZOL-5-YL)METHYLTHIO)-N'-SULFAMOYLPROPANIMIDAMIDE
3-[((2-[(DIAMINOMETHYLIDENE)AMINO]-1,3-THIAZOL-4-YL)METHYL)SULFANYL]-N-SULFAMOYLPROPANIMIDAMIDE
3-[({2-[(Diaminomethylene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide
3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide
3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N''-sulfamoylpropanimidamide
3-[(2-guanidinothiazol-4-yl)methylsulfanyl]-N-sulfamoyl-propanamidine
3-[[[2-[(AMINOIMINOMETHYL)AMINO]-4-THIAZOLYL]METHYL]THIO]-N-(AMINOSULFONYL)-PROPANIMIDAMIDE
3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanimidamide
3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpro
3-[2-(diaminomethyleneamino] thiazol-4-ylmethylthio]-N-sulphamoyl propionamidine
5QZO15J2Z8
76824-35-6
824F356
AB00383032_11
AB03031
AC-11713
AC1NWASH
AC1Q50E0
AC1Q50E1
agufam
AK229899
AKOS005460541
AKOS015994617
AKOS030573443
Amfamox
Antodine
Apo-Famotidine
Apogastine
BC203224
BDBM22891
BDBM50103514
Bestidine
BIDD:GT0759
Bio-0739
Blocacid
BPBio1_000098
Brolin
BSPBio_000088
C8H15N7O2S3
CAS-76824-35-6
CCG-100767
CCG-220104
CCG-221801
Cepal
CHEBI:4975
CHEMBL1318051
CHEMBL902
cid_5702160
Confobos
CPD000058961
Cronol
CS-2445
Cuantin
D00318
D0K0OZ
D0S7VH
Dibrit 40
Digervin
Dinul
Dipsin
Dispromil
Dispronil
Duovel
Durater
EU-0100497
Evatin
F 6889
F0530
Fadin
Fadine
Fadyn
Fagastine
Famo
Famocid
Famodar
Famodil
Famodin
Famodine
Famogard
Famonit
Famopsin
Famos
Famosan
Famotal
Famotep
Famotidina [Spanish]
famotidine
Famotidine (JP17/USP/INN)
Famotidine (Pepcid)
Famotidine [USAN:BAN:INN:JAN]
Famotidine for system suitability, European Pharmacopoeia (EP) Reference Standard
FAMOTIDINE PRESERVATIVE FREE
FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER
Famotidine, European Pharmacopoeia (EP) Reference Standard
Famotidine, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Famotidine, United States Pharmacopeia (USP) Reference Standard
Famotidinum [Latin]
Famotin
Famovane
Famowal
Famox
Famoxal
Famtac
Famulcer
Fanobel
Fanosin
Fanox
Farmotex
Ferotine
Fibonel
Fluxid
Fluxid (TN)
Fudone
Ganor
Gaster
Gastridan
Gastridin
Gastrion
Gastro
Gastrodomina
Gastrofam
Gastropen
Gastrosidin
H2 Bloc
Hacip
HMS1568E10
HMS2051A07
HMS2089I12
HMS2095E10
HMS2231I22
HMS3261D15
HS-0054
HSDB 3572
Huberdina
HY-B0377
InChI=1/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)
Ingastri
Invigan
K328
KM1798
L 643341
L003830
L013386
Lecedil
Logos
Lopac-F-6889
Lopac0_000497
LS-121117
MCULE-1972636463
Mensoma
Midefam
MK 208
MK-208
MLS000028583
MLS000758205
MLS001423994
MolPort-002-557-620
MolPort-003-941-395
MolPort-006-069-255
Mosul
Motiax
Muclox
Mylanta AR
N inverted exclamation marka-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine
N-(Aminosulfonyl)-3-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]propanimidamide
N-Sulfamoyl-3-((2-guanidinothiazol-4-yl)methylthio)propionamide
N'-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine
N'-[Aminosulfonyl]-3-[2-[diaminomethyleneamino]-4-thiazolyl)methylthio]-propanamidine
NC00017
NCGC00015446-01
NCGC00015446-02
NCGC00015446-03
NCGC00015446-04
NCGC00015446-05
NCGC00015446-06
NCGC00018276-01
NCGC00018276-02
NCGC00093899-01
NCGC00093899-02
NCGC00093899-03
NCGC00188952-01
NCGC00261182-01
Neocidine
Nevofam
Notidin
Novo-Famotidine
Nu-Famotidine
Nulceran
Nulcerin
Panalba
PDSP1_000398
PDSP2_000396
Pepcid (TN)
Pepcid AC
Pepcid AC Gelcaps
PEPCID COMPLETE
PEPCID PRESERVATIVE FREE
PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER
Pepcid RPD
Pepcidac
Pepcidin
Pepcidin Rapitab
Pepcidina
Pepcidine
Pepcidine (TN)
PepcidRPD
Pepdif
Pepdine
Pepdul
Pepfamin
Peptan
Peptidin
Peptifam
Pepzan
Prestwick_212
Prestwick2_000104
Prestwick3_000104
Propanimidamide, 3-(((2-((aminoiminomethyl)amino)-4-thiazolyl)methyl)thio)-N-(aminosulfonyl)-
Propanimidamide, 3-[[[2-[aminoiminomethyl)amino]-4-thiazoyl]methyl]thio]-N-(aminosulfonyl)
Propanimidamide, N'-(aminosulfonyl)-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)-
Purifam
Quamatel
Quamtel
Renapepsa
Restadin
Rogasti
Rubacina
s2078
SAM001247033
SBI-0050481.P003
SCHEMBL972
SCHEMBL974
Sedanium-R
Sigafam
SMR000058961
ST51001070
STK527689
Supertidine
Tairal
Tamin
Tipodex
TL8005267
Topcid
Tox21_500497
Ulcatif
Ulceprax
Ulcofam
Ulfagel
Ulfam
Ulfamid
Ulfinol
Ulgarine
UNII-5QZO15J2Z8
Vagostal
Weimok
Whitidin
XUFQPHANEAPEMJ-UHFFFAOYSA-
XUFQPHANEAPEMJ-UHFFFAOYSA-N
Yamarin
YM 11170
YM-11170
YM-1170

US Patents and Regulatory Information for PEPCID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Salix Pharms PEPCID famotidine FOR SUSPENSION;ORAL 019527-001 Feb 2, 1987 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 OTC Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Merck PEPCID PRESERVATIVE FREE famotidine INJECTABLE;INJECTION 019510-004 Nov 4, 1986 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for PEPCID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Salix Pharms PEPCID famotidine FOR SUSPENSION;ORAL 019527-001 Feb 2, 1987 ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North PEPCID famotidine TABLET;ORAL 019462-001 Oct 15, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Merck PEPCID famotidine INJECTABLE;INJECTION 019510-001 Nov 4, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for PEPCID
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Chewable Tablets 800 mg/ 10 mg/ 165 mg (OTC) ➤ Subscribe 2004-11-01

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Boehringer Ingelheim
Medtronic
QuintilesIMS
AstraZeneca
McKesson
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.